Detalles de la búsqueda
1.
Self-tuning Hamiltonian Monte Carlo for accelerated sampling.
J Chem Phys
; 159(23)2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108481
2.
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.
Cancer
; 127(12): 2015-2024, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739457
3.
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
Int J Cancer
; 134(11): 2534-46, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24293211
4.
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
Eur J Haematol
; 91(3): 219-227, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23679560
5.
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Eur J Haematol
; 91(1): 10-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23560441
6.
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.
Oncologist
; 17(5): 663-72, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22531362
7.
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Eur J Haematol
; 84(6): 474-83, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20331733
8.
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Br J Haematol
; 144(5): 653-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036082
9.
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Clin Lymphoma Myeloma
; 8(5): 294-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18854284
10.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Haematologica
; 91(1): 133-6, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16434383
11.
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience.
Hemasphere
; 4(5): e483, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33062948
12.
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.
Leuk Lymphoma
; 53(9): 1722-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22335534
13.
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Clin Lymphoma Myeloma Leuk
; 12(6): 423-32, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22981966
14.
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.
Leuk Lymphoma
; 52(5): 776-85, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21338282
15.
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.
PLoS One
; 6(11): e27560, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22110671
16.
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.
Leuk Lymphoma
; 51(8): 1444-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20496998
17.
R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study.
Leuk Lymphoma
; 49(6): 1081-6, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18569635
18.
The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.
Leuk Lymphoma
; 52(1): 148-9, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21067442
19.
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Blood
; 108(7): 2159-64, 2006 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16763209
Resultados
1 -
19
de 19
1
Próxima >
>>